“…The study conducted by López Grove et al (3) and published in this issue of Radiologia Brasileira focuses on the importance of contrast-enhanced MRI of the abdomen and magnetic resonance cholangiopancreatography for the noninvasive investigation of patients with PSC and for predicting disease progression, using the Anali scores together with clinical outcomes, such as liver transplantation, decompensation of liver cirrhosis, and death. Two other MRI signs were used for the PCS evaluation: periportal edema and heterogeneous liver parenchymal signal on diffusion-weighted imaging sequences, which are routinely obtained during contrast-enhanced MRI examinations of the upper abdomen.…”